DJE Kapital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$306M Sell
246,220
-11,677
-5% -$11.9M 5.76% 1
2026
Q1
$235M Buy
+257,897
New +$261M 5.2% 4
2025
Q4
Sell
-121,967
Closed -$94.5M 124
2025
Q3
$94.5M Hold
121,967
2.29% 17
2025
Q2
$94.5M Buy
121,967
+4,674
+4% +$3.63M 2.29% 17
2025
Q1
$93.5M Sell
117,293
-46,971
-29% -$39.1M 2.77% 12
2024
Q4
$127M Buy
+164,264
New +$136M 2.97% 11

Other funds holding LLY

DJE Kapital's LLY Position: Q2 2026 in Review

DJE Kapital reduced its Eli Lilly (LLY) stake by 4.5% in Q2 2026, selling an estimated $11.9M and leaving 246,220 shares worth $306M. The position accounts for 5.76% of the portfolio, ranked #1.

DJE Kapital first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • DJE Kapital held 246,220 shares of Eli Lilly worth $306M as of Q2 2026.
  • DJE Kapital sold 11,677 Eli Lilly shares in Q2 2026, an estimated $11.9M.
  • Eli Lilly made up 5.76% of DJE Kapital's portfolio in Q2 2026, its #1 holding.
  • DJE Kapital first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on DJE Kapital's 13F filing for Q2 2026, filed 4 Aug 2026.